162 related articles for article (PubMed ID: 36849137)
1. Inhibition of apoptosis through AKT-mTOR pathway in ovarian cancer and renal cancer.
Chen H; Zhang L; Zuo M; Lou X; Liu B; Fu T
Aging (Albany NY); 2023 Feb; 15(4):1210-1227. PubMed ID: 36849137
[TBL] [Abstract][Full Text] [Related]
2. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
3. [Total polyphenols of Cydonia oblonga inhibited proliferation and migration of renal cancer cells by PI3K/Akt/mTOR pathway].
Abudurousuli K; Han MY; Hailati S; Maihemuti N; Talihati Z; Nueraihemaiti N; Dilimulati D; Baishan A; Aikebaier A; Zhou WT
Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(4):1052-1063. PubMed ID: 38621912
[TBL] [Abstract][Full Text] [Related]
4. In-Silico Evaluation of Genetic Alterations in Ovarian Carcinoma and Therapeutic Efficacy of NSC777201, as a Novel Multi-Target Agent for TTK, NEK2, and CDK1.
Khedkar HN; Wang YC; Yadav VK; Srivastava P; Lawal B; Mokgautsi N; Sumitra MR; Wu ATH; Huang HS
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072728
[TBL] [Abstract][Full Text] [Related]
5. TTK inhibition increases cisplatin sensitivity in high-grade serous ovarian carcinoma through the mTOR/autophagy pathway.
Qi G; Ma H; Li Y; Peng J; Chen J; Kong B
Cell Death Dis; 2021 Dec; 12(12):1135. PubMed ID: 34876569
[TBL] [Abstract][Full Text] [Related]
6. High expression of KIF20A in bladder cancer as a potential prognostic target for poor survival of renal cell carcinoma.
Liu B; Su J; Fan B; Ni X; Jin T
Medicine (Baltimore); 2023 Jan; 102(2):e32667. PubMed ID: 36637953
[TBL] [Abstract][Full Text] [Related]
7. UBE2C affects breast cancer proliferation through the AKT/mTOR signaling pathway.
Lu ZN; Song J; Sun TH; Sun G
Chin Med J (Engl); 2021 Oct; 134(20):2465-2474. PubMed ID: 34620747
[TBL] [Abstract][Full Text] [Related]
8. Three hematologic/immune system-specific expressed genes are considered as the potential biomarkers for the diagnosis of early rheumatoid arthritis through bioinformatics analysis.
Cheng Q; Chen X; Wu H; Du Y
J Transl Med; 2021 Jan; 19(1):18. PubMed ID: 33407587
[TBL] [Abstract][Full Text] [Related]
9. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
Li Y; Li L
J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
[TBL] [Abstract][Full Text] [Related]
10. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of biomarkers for prostate cancer based on weighted gene co-expression network analysis.
Chen X; Wang J; Peng X; Liu K; Zhang C; Zeng X; Lai Y
Medicine (Baltimore); 2020 Apr; 99(14):e19628. PubMed ID: 32243390
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancer.
Chen J; Wu R; Xuan Y; Jiang M; Zeng Y
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32969465
[TBL] [Abstract][Full Text] [Related]
13. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
Li F; Guo P; Dong K; Guo P; Wang H; Lv X
J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
[No Abstract] [Full Text] [Related]
14. Comprehensively analyzing the genetic alterations, and identifying key genes in ovarian cancer.
Tang Q; Atiq W; Mahnoor S; Abdel-Maksoud MA; Aufy M; Yaz H; Zhu J
Oncol Res; 2023; 31(2):141-156. PubMed ID: 37304238
[TBL] [Abstract][Full Text] [Related]
15. Screening and identification of key biomarkers of papillary renal cell carcinoma by bioinformatic analysis.
Xu Y; Kong D; Li Z; Qian L; Li J; Zou C
PLoS One; 2021; 16(8):e0254868. PubMed ID: 34358255
[TBL] [Abstract][Full Text] [Related]
16. NUF2 promotes tumorigenesis by interacting with HNRNPA2B1 via PI3K/AKT/mTOR pathway in ovarian cancer.
Ren M; Zhao H; Gao Y; Chen Q; Zhao X; Yue W
J Ovarian Res; 2023 Jan; 16(1):17. PubMed ID: 36670423
[TBL] [Abstract][Full Text] [Related]
17. KIF20A as a potential biomarker of renal and bladder cancers based on bioinformatics and experimental verification.
Wang H; Ma X; Li S; Su J; Fan B; Liu B; Ni X
Aging (Albany NY); 2023 May; 15(11):4714-4733. PubMed ID: 37310408
[TBL] [Abstract][Full Text] [Related]
18. FMR1 is identified as an immune-related novel prognostic biomarker for renal clear cell carcinoma: A bioinformatics analysis of TAZ/YAP.
Wu S; He H; Huang J; Jiang S; Deng X; Huang J; Chen Y; Jiang Y
Math Biosci Eng; 2022 Jun; 19(9):9295-9320. PubMed ID: 35942760
[TBL] [Abstract][Full Text] [Related]
19. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatics analysis of C3 and CXCR4 demonstrates their potential as prognostic biomarkers in clear cell renal cell carcinoma (ccRCC).
Quan J; Bai Y; Yang Y; Han EL; Bai H; Zhang Q; Zhang D
BMC Cancer; 2021 Jul; 21(1):814. PubMed ID: 34266404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]